2026 NPPES data Pulmonary Disease Physician NPI 1205890761 M.D.
Verify on CMS →

NAJMUDDIN PATWA, M.D.

Pulmonary Disease Physician in WOBURN, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
651
Medicare Part D claims · 115 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
29%
generic claims · 71% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.4157/100
▲ 8 pts above national avg 83.1 · [object Object]
Industry payments
$215.91
5 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

NAJMUDDIN PATWA, M.D. reported a CMS MIPS final score of 91.4157/100 — above the 83.1 national average — and filed 651 Medicare Part D claims in 2023.

91.4157/100
MIPS score · +8 vs avg
651
Part D claims, 2023
29%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NAJMUDDIN PATWA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

91 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

NAJMUDDIN PATWA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NAJMUDDIN PATWA, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 04/13/2006

NPI 1205890761

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

651 55% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

MIPS final score

91.4157/100 8.315700000000007% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Massachusetts

How Pulmonary Disease Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Pulmonary Disease Physician share within Massachusetts

1. Pulmonary Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pulmonary Disease Physician share within Massachusetts

Medicare quality performance — MIPS

NAJMUDDIN PATWA, M.D.'s 2023 MIPS final score plotted against the Pulmonary Disease Physician national average

High performer (top quartile)
MIPS Final Score
91.4157/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pulmonary Disease Physician) — 91.4157/100 vs national avg 83.1

0%100%National avg83%91.4%
MIPS final score (Pulmonary Disease Physician) — 91.4157/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NAJMUDDIN PATWA, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 12 ALFRED STREET, WOBURN, MA, 01801, with a listed phone of (781) 756-4070. NPI 1205890761 was issued on 04/13/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PATWA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 651 prescription claims written by this provider, covering 115 Medicare beneficiaries and totaling roughly $306K in drug spend, split 71% brand-name and 29% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.4157/100 for the 2023 performance year (Quality 76.877), compared with the national average of 83.1.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

12 ALFRED STREET
WOBURN, MA 01801

Provider Details

NPI 1205890761
Specialty Pulmonary Disease Physician
Credentials M.D.
Gender Male
NPI Issued 04/13/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.4157
Final Score
Avg: 83.1
76.877
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where NAJMUDDIN PATWA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BETH ISRAEL LAHEY HEALTH SPECIALTY CARE, INC.
BURLINGTON, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NAJMUDDIN PATWA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$216

Largest payer

GlaxoSmithKline, LLC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to NAJMUDDIN PATWA, M.D.. To verify NAJMUDDIN PATWA, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

NAJMUDDIN PATWA, M.D. — brand share 71.0%
Specialty average (est.)

71% brand-name claims vs 29% generic, on 651 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

651
Total Claims
$306K
Total Drug Cost
115
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,136
Total Day Supply
33,385
Brand vs Generic
71% brand / 29% generic
Brand Drug Cost
$296K
Generic Drug Cost
$10K

Patient Demographics

Average Patient Age
75.2 years
Avg HCC Risk Score
1.40
Gender Split
59% female / 41% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What NAJMUDDIN PATWA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
70
Albuterol Sulfate Hfa
Albuterol Sulfate
63
Incruse Ellipta
Umeclidinium Bromide
59
Gabapentin
58
Breo Ellipta
Fluticasone/Vilanterol
55
Anoro Ellipta
Umeclidinium Brm/Vilanterol Tr
46
Symbicort
Budesonide/Formoterol Fumarate
44
Spiriva Respimat
Tiotropium Bromide
26
Prednisone
25
Flovent Hfa
Fluticasone Propionate
23

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How NAJMUDDIN PATWA, M.D. fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

NAJMUDDIN PATWA, M.D.'s 651 claims are below the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as PATWA.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NAJMUDDIN PATWA, M.D.'s specialty?
NAJMUDDIN PATWA, M.D. specializes in Pulmonary Disease Physician and practices in WOBURN, Massachusetts. Credentials: M.D..
How much does NAJMUDDIN PATWA, M.D. prescribe under Medicare Part D?
In 2023, NAJMUDDIN PATWA, M.D. wrote 651 Medicare Part D claims totaling $306K in drug costs for 115 beneficiaries.
What is NAJMUDDIN PATWA, M.D.'s Medicare quality score?
NAJMUDDIN PATWA, M.D. has a CMS MIPS Final Score of 91.4157/100 (Quality: 76.877). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NAJMUDDIN PATWA, M.D. located?
NAJMUDDIN PATWA, M.D. is located at 12 ALFRED STREET, WOBURN, MA, 01801. Phone: (781) 756-4070.
What is NAJMUDDIN PATWA, M.D.'s NPI number?
NAJMUDDIN PATWA, M.D.'s National Provider Identifier (NPI) is 1205890761, issued on 04/13/2006.
Does NAJMUDDIN PATWA, M.D. prescribe more brand-name or generic drugs?
NAJMUDDIN PATWA, M.D.'s prescribing is 71% brand-name and 29% generic drugs by claim count, with $296K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does NAJMUDDIN PATWA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, NAJMUDDIN PATWA, M.D.'s most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Incruse Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NAJMUDDIN PATWA, M.D. accept Medicare?
NAJMUDDIN PATWA, M.D. appears in CMS Medicare data with 651 Part D claims and 115 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NAJMUDDIN PATWA, M.D.'s credentials?
NAJMUDDIN PATWA, M.D.'s NPI is 1205890761 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology